Fall Prevention in Stroke Survivors: Tailored Interventions Work
Stroke survivors face 1.5x higher fall risk. New Australian trial evidence supports home-based, individualized programs to reduce falls in this vulnerable group.
Sarah Tanaka
Cardiology Reporter
CardiologyCardiovascular ResearchHeart DiseaseInterventional Procedures
About Sarah
Sarah Tanaka is an interventional cardiologist at Straub Medical Center in Honolulu. Fellowship-trained in structural heart disease, she reports on cardiovascular research, heart disease treatment advances, and clinical trial outcomes in cardiology for Hawaii Medical Journal.
Articles by Sarah
Rethinking eGFR Monitoring in Chronic Kidney Disease
New evidence challenges single eGFR measurements in CKD, suggesting GFR decline trajectory is more clinically actionable than point-in-time precision.
Iran Conflict, Pharma Supply Chain & Pfizer Lyme Vaccine
Analysts warn Iran conflict could disrupt pharma supply chains via Strait of Hormuz, while Pfizer's Lyme disease vaccine shows promise in Phase 3 trials.
How a Texas Couple Got Rich Off Out-of-Network Bills
Scott and Alla LaRoque built wealth through HaloMD, exploiting federal arbitration meant to protect patients from surprise medical bills.
FDA Approves High-Dose Wegovy 7.2mg for Obesity in 2026
The FDA approved high-dose semaglutide 7.2mg (Wegovy) for obesity, showing 18.7% mean weight loss in Phase 3 trials amid new Trump administration drug pricing agreements.
MedPAC 2026: $76B Medicare Advantage Overpayment Warning
MedPAC projects $76 billion in excess Medicare Advantage payments in 2026, urging Congress to reform spending as industry pressure mounts.
Regulating Invasive Cosmetic Procedures to Reduce Harm
Adverse events and regulatory gaps in cosmetic procedures prompt calls for structural reform, following high-profile cases like the 2024 death of Alice Webb after a BBL.
Radial: $3.5B Nonprofit Reshaping Science for AI Era
Seemay Chou launches Radial, a $3.5B nonprofit funding bold, high-risk science projects and building AI-ready data infrastructure like the Diffuse database.
Lancet Correction: Prostate Cancer Radiotherapy Meta-Analysis
The Lancet issued a correction for figure-labeling errors in a 2026 meta-analysis on hormone therapy and radiotherapy for recurrent prostate cancer.
Wegovy Linked to Higher Ischemic Optic Neuropathy Risk
New FAERS analysis finds Wegovy carries nearly fivefold higher ischemic optic neuropathy risk vs. Ozempic, raising ocular safety concerns for GLP-1 drugs.